Inmedix immuno-autonomics strategies projected to save payers billions

Immuno-autonomics treatment may affect the way patients, rheumatologists, the pharmaceutical industry and especially payers view treatment strategies in rheumatoid arthritis (RA).

Click below to read the full press release.